Teleflex Incorporated Signs New Agreement with Premier Inc. for Implantable Infusion Ports

WAYNE, Pa.--()--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced a new group purchasing agreement with Premier Inc. – a leading healthcare improvement company, uniting an alliance of approximately 3,750 US hospitals and 130,000 other providers to transform healthcare. The new agreement covers the Polysite® Low Profile Hybrid Ports. The agreement begins November 1, 2016, and extends through October 31, 2019.

The Polysite® Low Profile Hybrid Ports are designed to enhance patient comfort while simultaneously providing clinicians with unique product enhancements. The low-profile design incorporates hybrid technology with a durable titanium reservoir and a lightweight atraumatic-angled shell. The ports have a large septum for easy access and include a radiopaque locking collar for safe attachment to catheters. They are available in both pressure-injectable and non-pressure-injectable options in 6Fr, 7Fr and 8Fr sizes.

“Arrow® Interventional Access products from Teleflex provide economical solutions and help clinicians to reduce complications,” said Jay White, President and General Manager, Vascular Division of Teleflex. “We’re pleased to offer Premier members the clinical and financial benefits of the Polysite Ports under this new agreement.”

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose-driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch® and Weck® – trusted brands united by a common sense of purpose.

Polysite is a registered trademark of Perouse Medical SAS.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Teleflex, the Teleflex logo, Arrow, Deknatel, Hudson RCI, LMA, Pilling, Rusch and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries.
© 2016 Teleflex Incorporated. All rights reserved. MC-002818

Contacts

Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President, Investor Relations
610-948-2836

Release Summary

Teleflex Incorporated Signs New Agreement with Premier Inc. for Implantable Infusion Ports

Contacts

Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President, Investor Relations
610-948-2836